| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |